FFR-Guided Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Diabetes

Heart, Artery and Coronary Diseases

Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial

Lancet

Fearon WF, Zimmermann FM, Ding VY, Takahashi K, Piroth Z, van Straten AHM, Szekely L, Davidavičius G, Kalinauskas G, Mansour S, Kharbanda R, Östlund-Papadogeorgos N, Aminian A, Oldroyd KG, Al-Attar N, Jagic N, Dambrink JE, Kala P, Angerås O, MacCarthy P, Wendler O, Casselman F, Witt N, Mavromatis K, Miner SES, Sarma J, Engstrøm T, Christiansen EH, Tonino PAL, Reardon MJ, Otsuki H, Kobayashi Y, Hlatky MA, Mahaffey KW, Desai M, Woo YJ, Yeung AC, Pijls NHJ, De Bruyne B

doi: 10.1016/S0140-6736(25)00505-7

Heart, Artery and Coronary DiseasesTherapy and Intervention

Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes

Circulation

Collet C, Munhoz D, Mizukami T, Sonck J, Matsuo H, Shinke T, Ando H, Ko B, Biscaglia S, Rivero F, Engstrøm T, Arslani K, Leone AM, van Nunen LX, Fearon WF, Christiansen EH, Fournier S, Desta L, Yong A, Adjej J, Escaned J, Nakayama M, Eftekhari A, Zimmermann FM, Sakai K, Storozhenko T, da Costa BR, Campo G, West NEJ, De Potter T, Heggermont W, Buytaert D, Bartunek J, Berry C, Collison D, Johnson T, Amano T, Perera D, Jeremias A, Ali Z, Pijls NHJ, De Bruyne B, Johnson NP

doi: 10.1161/CIRCULATIONAHA.124.069450

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Society Guidelines on Trends in Use of Newer P2Y(12) Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

J Am Heart Assoc

Mohamed MO, Kontopantelis E, Alasnag M, Abid L, Banerjee A, Sharp ASP, Bourantas C, Sirker A, Curzen N, Mamas MA

doi: 10.1161/JAHA.124.034414

Heart, Artery and Coronary DiseasesTherapy and Intervention

Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis

JACC Cardiovasc Interv

Amat-Santos IJ, García-Gómez M, Avanzas P, Jiménez-Diaz V, Alonso-Briales JH, de la Torre Hernández JM, Sanz-Sánchez J, Diarte-de Miguel JA, Sánchez-Recalde Á, Nombela-Franco L, Jiménez-Mazuecos J, Serra V, Nogales-Asensio JM, García-Blas S, Gómez-Menchero A, Del Valle R, Mayor Déniz C, Al Houssaini W, Veiga-Fernández G, Diez-Gil JL, Jimeno Sánchez J, López Menéndez J, Fernández-Cordón C, Gómez-Salvador I, Bustamante-Munguira J, Kedhi E, San Román JA

doi: 10.1016/j.jcin.2024.09.003

Therapy and Intervention

Sex Differences in Patients Undergoing Left Main Stem Percutaneous Coronary Intervention for Stable Angina: Data From a National Registry

J Am Heart Assoc

Shamkhani W, Zathar Z, Khattak S, Nolan J, Chieffo A, Kinnaird T, Mamas MA

doi: 10.1161/JAHA.124.036569

Heart, Artery and Coronary DiseasesTherapy and Intervention

Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications

J Am Coll Cardiol

Sandner S, Redfors B, An KR, Harik L, Heise R, Di Franco A, Fremes SE, Hare DL, Kulik A, Lamy A, Peper J, Ruel M, Ten Berg JM, Willemsen LM, Zhao Q, Zhu Y, Wojdyla DM, Bhatt DL, Alexander JH, Gaudino M

doi: 10.1016/j.jacc.2024.04.046

Heart, Artery and Coronary DiseasesTherapy and Intervention

Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers After Coronary Artery Bypass Graft Surgery: A Population-Based Cohort Study

J Am Heart Assoc

Barry AR, Helisaz H, Safari A, Loewen P

doi: 10.1161/JAHA.124.035215

Heart, Artery and Coronary DiseasesTherapy and Intervention

Ten years survival benefit and appropriateness of surgical versus percutaneous revascularization in synergy between percutaneous coronary intervention with taxus and cardiac surgery randomized trial

Eur J Cardiothorac Surg

Serruys PW, Ninomiya K, Revaiah PC, Gao C, Garg S, van Klaveren D, Onuma Y, Kappetein AP, Davierwala P, Mack M, Thuijs DJFM, Taggart DP, Milojevic M

doi: 10.1093/ejcts/ezae391

Heart, Artery and Coronary Diseases

Body Mass Index and 10-Year Clinical Outcomes After Percutaneous Coronary Intervention-Interaction with Age, Sex, Diabetic Status and Clinical Presentation

J Clin Med

Ndrepepa G, Kufner S, Cassese S, Joner M, Xhepa E, Sager HB, Schunkert H, Kastrati A

doi: 10.3390/jcm14051413

Related content

Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial

Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes

Impact of Society Guidelines on Trends in Use of Newer P2Y(12) Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis

Sex Differences in Patients Undergoing Left Main Stem Percutaneous Coronary Intervention for Stable Angina: Data From a National Registry

Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications

Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers After Coronary Artery Bypass Graft Surgery: A Population-Based Cohort Study

Ten years survival benefit and appropriateness of surgical versus percutaneous revascularization in synergy between percutaneous coronary intervention with taxus and cardiac surgery randomized trial

Body Mass Index and 10-Year Clinical Outcomes After Percutaneous Coronary Intervention-Interaction with Age, Sex, Diabetic Status and Clinical Presentation